- Zepp Health Corp ZEPP reported second-quarter FY21 revenue growth of 61.4% year-on-year to $284.2 million (RMB1.8 billion), beating the analyst consensus of $280 million.
- Revenue from Xiaomi Corp XIACF XIACY wearable products and self-branded products increased due to the launch of Mi Band 6 and sales of premium GT series, basic Bip and Pop models, and rugged T-Rex.
- Margin: The gross margin contracted 30 bps to 22%.
- Adjusted income per ADS of $0.31 beat the analyst consensus of $0.13.
- Zepp held $215.7 million in cash and equivalents.
- Drivers: Total units shipped rose 29.2% Y/Y to 11.5 million.
- The unit shipments of Amazfit and Zepp-branded products increased 114.3% Y/Y.
- Unit shipment for Xiaomi wearable products rose 22% Y/Y.
- Zepp topped the high end of its guidance range for Q2, which included an 81% increase in its own Amazfit and Zepp branded product revenue and a 53% increase in revenue from products designed and built for Xiaomi.
- Outlook: Zepp sees Q3 revenue of RMB1.6 billion - RMB1.8 billion.
- Price Action: ZEPP shares traded lower by 0.51% at $9.76 on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in